Reyvow (lasmiditan) — Medica
acute treatment of migraine with or without aura
Preferred products
- triptans (e.g., almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zolmitriptan)
Initial criteria
- Patient has a diagnosis of acute migraine
- age ≥ 18 years
- Patient has tried at least one triptan therapy OR patient has a contraindication to triptan(s)
Approval duration
1 year